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Abstract
Background: MicroRNAs, post-transcriptional regulators of eukaryotic gene expression, are implicated in host
defense against pathogens. Viruses and bacteria have evolved strategies that suppress microRNA functions,
resulting in a sustainable infection. In this work we report that Helicobacter pylori, a human stomach-colonizing
bacterium responsible for severe gastric inflammatory diseases and gastric cancers, downregulates an embryonic
stem cell microRNA cluster in proliferating gastric epithelial cells to achieve cell cycle arrest.
Results: Using a deep sequencing approach in the AGS cell line, a widely used cell culture model to recapitulate
early events of H. pylori infection of gastric mucosa, we reveal that hsa-miR-372 is the most abundant microRNA
expressed in this cell line, where, together with hsa-miR-373, it promotes cell proliferation by silencing large tumor
suppressor homolog 2 (LATS2) gene expression. Shortly after H. pylori infection, miR-372 and miR-373 synthesis is
highly inhibited, leading to the post-transcriptional release of LATS2 expression and thus, to a cell cycle arrest at
the G1/S transition. This downregulation of a specific cell-cycle-regulating microRNA is dependent on the
translocation of the bacterial effector CagA into the host cells, a mechanism highly associated with the
development of severe atrophic gastritis and intestinal-type gastric carcinoma.
Conclusions: These data constitute a novel example of host-pathogen interplay involving microRNAs, and unveil
the couple LATS2/miR-372 and miR-373 as an unexpected mechanism in infection-induced cell cycle arrest in
proliferating gastric cells, which may be relevant in inhibition of gastric epithelium renewal, a major host defense
mechanism against bacterial infections.
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Background
MicroRNAs (miRNAs) are small endogenous non-coding
RNAs that have recently emerged along with small inter-
fering RNAs (siRNAs) as key components of the RNA
silencing machinery in eukaryotes. Most of them are
involved in the tight control of development and cell
cycle progression [1,2], and are frequently deregulated in
severe pathologies, notably in cancers [3,4]. However, the
importance of RNA silencing has been primarily demon-
strated in plant defense mechanisms against viruses,
where it protects the host by processing long double-
stranded (ds)RNAs into siRNAs which, like miRNAs, are
loaded onto Argonaute-RNA induced silencing com-
plexes (AGO-RISC) [5] to downregulate gene expression
and therefore inhibit viral replication. Recently, evidence
has been found to show that miRNAs are also implicated
in host defense against diverse pathogens, including
viruses, bacteria and parasites. For example, the human
hsa-miR-32 counteracts the accumulation of primate
foamy virus type 1 (PFV-1) in human cells, targeting
directly the PFV-1 genome and inhibiting its translation
[6]. Similarly, the Arabidopsis thaliana miR-393, a patho-
gen-associated molecule pattern (PAMP)-responsive
miRNA, contributes to the resistance of the plant against
av i r u l e n tPseudomonas syringae (P. syringae) bacterial
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any medium, provided the original work is properly cited.strain [7]. In response, pathogens have evolved strategies
to counteract RNA silencing. A number of pathogen-
derived RNA silencing suppressors have been described
in eukaryotes, such as the p19 protein of the tomato
bushy stunt virus, which selectively sequesters short dou-
ble-stranded RNA (dsRNA) [8], the Tas protein of
PFV-1, which blocks the miRNA-directed silencing [6] or
the AvrPto, AvrPtoB and HopT1 proteins of P. syringae,
which suppress miR-393a/b biogenesis and activity [9].
In mammals, the miRNA pathway is a key actor in
innate immunity, and viruses are able to exploit the non-
antigenic potential of miRNAs to favor their replication
[10]. Two miRNAs, miR-146a and miR-155, are major
regulators of innate immune responses in monocytes/
macrophages [11-13]. Both are strongly induced through
Toll-like receptor (TLR) engagement after PAMP recog-
nition and nuclear factor (NF)B activation. In turn, they
target the TLR signaling cascades and thus, moderate the
life-threatening overproduction of inflammatory cyto-
kines through a negative feedback loop. Recently, the let-
7 family has been identified as a new actor of the innate
response [14]. Indeed, during Salmonella infection of
murine macrophages, TLR4 signaling triggered by bacter-
ial lipopolysaccharide (LPS) leads to the repression of let-
7 family and results in the expression of its targets, the
proinflammatory interleukin (IL)-6 and the anti-inflam-
matory IL-10, thus modulating tightly the immune
response [14,15].
However, the epithelial barrier constitutes the first line
of defense against pathogens. In contrast to results
obtained in immune cells, miR-155 and miR-146 were not
found upregulated in mouse lungs, among the numbers of
miRNAs rapidly induced after bacterial LPS exposure, sug-
gesting that epithelial cells may express a different set of
miRNAs than immune cells in response to pathogens [16].
The importance of miRNAs in epithelial defense against
pathogens was highlighted in biliary epithelial cells
infected with the protozoan parasite Cryptosporidium
parvum, an infection model in which let-7i and miR-513
contribute to the epithelial immune response. Indeed,
upon C. parvum infection, these miRNAs are downregu-
lated, in a MyD88/NFB-dependent manner for let-7i,
leading to the upregulation of TLR4 and B7-H1 expres-
sion, respectively [17-19].
Helicobacter pylori is a Gram-negative microaerophilic
bacterium which chronically infects the gastric mucosa of
about half of the world population, and constitutes the
primary etiological cause of gastritis, peptic ulcer and
gastric cancers [20]. The most virulent strains, associated
with a higher risk of gastric adenocarcinomas [21], har-
bor in their genome a cluster of 31 genes called the cag
pathogenicity island (cagPAI), which encode a type IV
secretion system (T4SS) and the CagA toxin. This T4SS
interacts with host cell surface and injects the CagA
protein into the cell cytoplasm [22]. The translocated
CagA interferes then with intracellular signaling path-
ways, which subsequently alters cell-to-cell adhesion, cell
polarity and proliferation [23-25]. A functional T4SS is
also essential for the induction of innate immune
response, characterized by NFB activation and IL-8 pro-
duction in gastric epithelial cells [26].
The extent to which miRNAs contribute to the gastric
epithelial cell response to H. pylori infection has been
little explored to date [27]. So far, only two miRNAs,
miR-21 and miR-155, have been reported upregulated in
both H. pylori-infected human gastric mucosa and
inv i t r ocell culture [28,29]. As the gastric epithelial cells
are the first line of defense against H. pylori,t r i g g e r i n g
the immune response, it is relevant to further assess how
miRNA are modulated upon H. pylori infection in these
cells. With this aim, we used a common gastric epithelial
cell model, the human AGS cell line [30]. First, we
employed a deep-sequencing approach to identify the
AGS miRNAs profile in basal and infection conditions.
Surprisingly, the most abundant one, miR-372, belongs
to a miRNA cluster, miR-371-372-373, specifically
expressed in embryonic stem cells. Moreover, this cluster
is repressed upon H. pylori infection in a CagA-depen-
dent manner. The repression of miR-372 and miR-373 is
associated with the upregulation of their target, the cell
cycle regulator large tumor suppressor homolog 2
(LATS2), leading to the inhibition of cell cycle progres-
sion in H. pylori-infected cells.
Results
AGS cell line expresses a particular set of miRNAs
The AGS cell line is widely used in in vitro experiments
to recapitulate early events of H. pylori infection occur-
ring within actively replicating gastric mucosa [31,32].
To address the complete miRNA profile of the AGS cell
line, we employed a high-throughput pyrosequencing
approach. A cDNA library of growing AGS cells was gen-
erated and submitted to ‘454’ technology. A total of
44,012 sequences were analyzed, resulting in 25,348
(57.6%) sequences matching with mature human miRNA
sequences of the miRBase 14.0 [see Additional file 1,
Table S1]. The other sequences corresponded to various
RNA degradation products or unidentified sequences.
Mature miRNAs identified with this method can be clas-
sified in function of their respective number of reads
(Figure 1A), their genomic organization in clusters
(Figure 1B) or their function previously assigned to them
in other studies [see Additional file 1, Table S2]. We
decided to restrict our analysis to the 38 most abundant
miRNAs (>100 reads, Figure 1A). Consistent with their
respective genomic annotations, many of the mature
miRNAs identified were organized in clusters. Thus, the
miRNA signature of AGS cells can be summarized into
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miR-17-92 cluster and the miR-23b-27b-24-2 cluster,
which represent 18.6%, 12.4% and 12.1% of total number
of reads, respectively (Figure 1B). Members of the miR-
200 and let-7 families were also highly represented: miR-
200b, miR-200c and let-7a being the most expressed
members of these families in AGS cells [see Additional
file 1, Table S1].
The expression of some of these miRNAs was confirmed
by quantitative real time PCR (RT-qPCR) (Figure 1C)
and northern blot (data not shown). As expected, all
tested miRNAs present in our miRNA sequencing library
were also detected by these techniques. However, two
miRNAs, miR-155 and miR-146a, reported to be present
i nA G Sc e l l s[ 3 3 ]a n da b s e n tf r o mo u rl i b r a r yw e r e
weakly detected by RT-qPCR (close to the detection
threshold; data not shown), suggesting that our library
might lack some miRNAs faintly expressed in this cell
line.
miR-372 and miR-373 regulate LATS2 expression in AGS
cells
The peculiarity of the AGS miRNA repertoire, which
besides containing ubiquitous miRNAs such as miR-16,
miR-21, miR-17 and miR-92, resides in the outstanding
abundance of miR-372, which was present in the range of
10
6 copies/ng total RNA or 10
4 copies per cell (see Meth-
ods). Intriguingly, miR-372 is an embryonic stem-cell-spe-
cific miRNA [34], also found highly expressed in placenta
[35]. It belongs to a cluster located on the chromosomic
Figure 1 Micro RNA (miRNA) expression profile in AGS cells. (A) miRNA content of AGS cells was determined by high-throughput ‘454’
pyrosequencing [see Additional File 1, Table S1]. Bars indicate the number of reads for each miRNA out of 25,348 miRNA matching sequences.
Only the 42 most abundant miRNAs are plotted in order of decreasing number of reads. Black bars indicate mature miRNAs belonging to the
miR-371-372-373 cluster. (B) Pie chart represents the percentage and clustering of the most highly expressed miRNAs in AGS cells. Percentage
represents the number of reads of each miRNA relative to the total number of reads. (C) Endogenous expression of some mature miRNAs in
AGS cells was measured by quantitative real time PCR (RT-qPCR). Bars indicate the relative expression of each miRNA normalized to U6 small
nuclear RNA (snRNA) (RNU6B). Data are mean ± SD of three independent experiments.
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them highly expressed in AGS cells: miR-371-5p, miR-
371-3p, miR-372 and miR-373 (Figure 1A, black bars).
miR-372 or miR-373 expression is considered as a rare
event in tumors, and has only been found in testicular
germ cell tumors [36], esophageal tumors [37] and thyroid
adenomas [38].
In testicular and esophageal tumors, in which they are
abundant, miR-372 and miR-373 have been reported to
act as oncogenes repressing LATS2, a serine-threonine
kinase involved in cell cycle regulation [36,37]. On
performing immunoblot analysis of LATS2, we did not
detect LATS2 in AGS cells, in contrast to the other gastric
cell line MKN-74 and the cervix cancer cell line HeLa
(Figure 2B, upper panel). It appears that the LATS2 level
was inversely correlated to the expression of miR-372 and
miR-373 in these cell lines (Figure 2B, lower panel). These
results suggest that LATS2 could be repressed at the post-
transcriptional level by miR-372 and miR-373 in AGS
cells. To validate this hypothesis, we transfected into AGS
cells the luciferase sensor pGL3-LATS2, containing the 3’
untranslated region (UTR) of LATS2, which harbors two
miR-372 and miR-373 pairing sites [36] downstream to
the firefly luciferase coding sequence (Figure 2A). As
expected from cells expressing high miR-372 and miR-373
levels, we observed a 60% inhibition of luciferase expres-
s i o n ,a sc o m p a r e dt ot h ec o n t r o lp G L 3r e p o r t e r( F i g u r e
2C). No such inhibition was observed when the pGL3-
LATS2 vector was transfected in MKN-74 cells, which
express very low miR-372 and miR-373 levels [see Addi-
tional File 2, Figure S1]. This repression was dependent on
the two miR-372 and miR-373 binding sites located in the
LATS2 3’UTR, as no significant inhibition was observed in
AGS cells transfected with the pGL3-LATS2mut vector
mutated for these sites [see Additional File 2, Figure S1].
To confirm the role of miR-372 and miR-373 in this
repression, we designed antisense oligonucleotides (as372,
as373) and their scrambled controls (sc372, sc373) in
order to block these miRNAs. The levels of detectable
miR-372 or miR-373 were each specifically decreased by
90% by as372/as373, as verified by RT-qPCR and northern
blot analysis [see Additional File 3, Figure S2A,B]. This
decrease leads to an accumulation of LATS2 protein in
as372-373-treated cells, compared to sc372-373-treated
cells [see Additional File 3, Figure S2D]. We transfected
either pGL3-LATS2, or the control pGL3 vector, together
with as372-373 or the control sc372-373, and analyzed the
luciferase activity. In as372-373 treated cells, the firefly
luciferase expression was significantly derepressed and
almost reached the levels of that of the control vector
(Figure 2C), contrarily to the cells treated with sc372-373,
which did not affect the basal miR-372 or miR-373 levels.
Altogether, these results indicate that LATS2 is indeed a
direct target of miR-372 and miR-373 in AGS cells.
Inhibition of LATS2 by miR-372 and miR-373 confers a
growth advantage to cells [36,37]. To confirm that LATS2
is a functional target of miR-372 and miR-373 in AGS
cells, we analyzed cell cycle progression of either as372-
373-treated or LATS2-transfected cells using the 5-
bromo-2’-deoxyuridine (BrdU) incorporation method,
which measures the rate of DNA synthesis occurring in
the S phase of the cell cycle. The as372-373-treated AGS
cells presented a significantly delay of about 50% in S
phase progression compared to sc372-373 treated cells
(Figure 2D). Similarly, overexpression of LATS2 [see Addi-
tional File 3, Figure S2D] by transfecting the pCMVmyc-
LATS2 vector, which allows the expression of the human
LATS2 cDNA, resulted in a similar inhibition of BrdU
incorporation see Additional File 3, Figure S2E]. The
delays in cell cycle progression exhibited by either as372-
373-transfected or LATS2-transfected cells resulted
in decreased cell proliferation rates of AGS cells [see Addi-
tional File 3, Figure S2C,E], whereas the growth of MKN-
74 cells, which expressed LATS2 in basal conditions, was
not inhibited by the ectopic expression of LATS2 [see
Additional File 3, Figure S2E]. Altogether, these results
indicate that LATS2 is a functional target of miR-372 and
miR-373 in AGS cells and that the high expression of
miR-372 and miR-373 confers to them a growth advantage
through the inhibition of LATS2 expression.
The miR-371-372-373 cluster is downregulated in
response to H. pylori infection
To analyze miRNA changes in AGS cells upon H. pylori
infection, a cDNA library of AGS cells cocultured with the
bacteria for 5 h was generated and also submitted to ‘454’
pyrosequencing. In all, 43,863 sequences were analyzed,
resulting in 17,778 (40.6%) sequences matching with
mature human miRNA sequences of the miRBase 14.0
[see Additional File 1, Table S1]. The pyrosequencing data
were analyzed by a two-dimensional scatter plot, which
compares the number of reads for a same miRNA from
uninfected and infected AGS cells (Figure 3A). The major-
ity of miRNAs appear along the trend line, indicating that
they were unaffected by the infection. The miRNAs
affected by H. pylori appear either above (downregulated)
or below (upregulated) the trend line. Interestingly, miR-
372, which is the most abundant miRNA expressed
in AGS cells, was also the most significantly repressed
upon infection (Figure 3A, Fisher’s exact test, P value =
5.1 × 10
-13). Other members of the miR-371-372-373 clus-
ter, miR-373 and miR-371-5p, also appeared significantly
downregulated upon infection (Figure 3A, P values = 8.3 ×
10
-8 and 0.009, respectively). These results suggest that
this cluster is highly repressed upon infection and
prompted us to further analyze its regulation upon
H. pylori infection. With this aim, AGS cells were cultured
i nt h ep r e s e n c eo ft h eH. pylori 26695 strain at a
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372-373 cluster expression was analyzed 24 h later.
Mature miR-371-3p, miR-372 and miR-373 were all signif-
icantly downregulated (up to 50%) upon infection, as
shown by RT-qPCR and northern blot analysis (Figure 3B,
C, respectively). This repression was not the consequence
of a global effect on the miRNA pathway, as some other
miRNAs were differently modulated upon infection. For
example, miR-106b and miR-19b were slightly repressed
while miR-21 was upregulated upon infection, in concor-
dance with prior observations [29]. We also found miRNA
levels unchanged upon infection, such as miR-93 and
miR-320 (Figure 3B). Downregulation of miR-372 and
miR-373 upon infection was also shown by northern blot
Figure 2 miR-372 and miR-373-mediated regulation of large tumor suppressor homolog 2 (LATS2) translation and AGS cell
proliferation. (A) Schematic representation of the pGL3 vector (control) and the pGL3-LATS2 sensor containing the 3’ untranslated region (UTR)
of the LATS2 human gene, which harbors two predicted miR-372 and miR-373 target sequences [36]. Also shown is the predicted base pairing
formed between miR-372 or miR-373 with each of the LATS2 3’UTR binding sites as predicted by http://pictar.mdc-berlin.de. Seed regions of
miR-372 and miR-373 are underlined. (B) LATS2 levels and mature miR-372 and miR-373 expression in AGS, MKN-74 and HeLa cells were
determined by immunoblot and northern blot, respectively. a-Tubulin and U6 small nuclear RNA (snRNA) were used as loading controls. (C) The
pGL3 and pGL3-LATS2 vectors were transfected into either parental AGS (mock), or cells treated with 100 nM of as372-373 or the sc372-373
control oligonucleotides. Transfection efficiency was assessed with the pRL-SV40 vector. Luciferase activities were measured 48 h post
transfection. Bars indicate the relative firefly luciferase activity normalized to the Renilla activity and compared to pGL3. Data are mean ± SD from
three independent experiments. *P < 0.05; **P < 0.01. (D) The DNA synthesis rate was measured by 5-bromo-2’-deoxyuridine (BrdU)
incorporation (10 nM for 1 h) in untreated (mock) AGS cells or cells treated for 48 h with 100 nM as372-373 or sc372-373 or transfected with the
pCMVmyc-LATS2 vector. Bars represent the relative BrdU incorporation compared to that of untreated cells. Data are mean ± SD of three
independent experiments. **P < 0.01.
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(miRNAs) content of AGS cells cocultured with H. pylori was determined by high-throughput ‘454’ pyrosequencing. The graph represents the
miRNAs content in reads of uninfected AGS cells (y axis) versus infected cells (x axis). miR-372, miR-373 and miR-371-5p are shown (empty plots).
The trend line is represented, R
2 = 0.9556 [see Additional File 1, Table S1 for total number of reads of each miRNA and Fisher’s exact test P
values]. (B) Endogenous expression of mature miR-371-3p, miR-372 and miR-373 (black bars), or miR-19b, miR-106b, miR-21 and miR-93 (grey
bars), was determined by quantitative real time PCR (RT-qPCR) in AGS cells 24 h post infection at multiplicity of infection (MOI) 100. Bars indicate
the relative miRNA expression normalized to SNORD49A (RNU49) and compared to uninfected AGS cells. Data represent mean ± SD of three
independent experiments. **P < 0.01; ***P < 0.001. (C) Northern blot analysis of mature miR-372, miR-373 and pre-miR-373 expression in
uninfected (lane 2) or H. pylori-infected AGS cells (lane 3) in the same conditions as in (A). lane 1: M, size marker (nucleotides). A representative
blot is shown. (D,E) Expression of the primary miR-371-372-373 cluster transcript after different time of infection (MOI 100) (D), and different MOI
(6 h post infection) (E). Bars indicate the relative primary polycistronic miRNA transcript (pri-miRNA) expression determined by RT-qPCR,
normalized to the ribosomal protein P0 mRNA and compared to uninfected AGS cells. A representative experiment is shown.
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miRNA precursors (pre-miRNA) were even more strongly
repressed than the mature forms (Figure 3C, upper part of
the blot for miR-373). These findings suggest that the reg-
ulation took place at an initial step of miR-371-372-373
biogenesis. We confirmed this hypothesis by RT-qPCR on
the primary polycistronic miRNA transcript (pri-miRNA)
of the cluster (Figure 3D,E). Indeed, the pri-miRNA was
rapidly downregulated upon H. pylori infection, as soon as
2 h post-infection at MOI 100 (Figure 3D), and in a MOI-
dependent manner (Figure 3E). Altogether, these results
show that the miR-371-372-373 cluster was strongly
decreased at the pri-miRNA level shortly upon H. pylori
infection.
miR-371-372-373 cluster is repressed in a CagA-
dependent manner
To assess whether the downregulation of the miR-371-
372-373 cluster was related to a functional H. pylori cag-
PAI, we compared the effect of wild-type bacteria to those
of isogenic mutants deleted either for the cagA (ΔCagA)
or for the T4SS constituent cagE (ΔCagE) genes. As pre-
viously described [26,39], these mutants like wild-type
H. pylori induced vacuolization of AGS cells, an effect due
to the vacuolating toxin VacA, but failed to provoke cell
elongation and scattering, the so-called ‘hummingbird’
phenotype, characteristic of AGS cells infected with wild-
type H. pylori [see Additional File 4, Figure S3A]. More-
over, these mutants were impaired in their proinflamma-
tory effects on AGS cells, as measured by NFB activation
and IL-8 secretion [see Additional File 4, Figure S3B,C].
Interestingly, both mutants have a very weak effect on the
miR-371-372-373 cluster (Figure 4A). Indeed, when AGS
cells were cocultivated with the ΔCagA or ΔCagE mutants,
which are, respectively, unable to produce the CagA viru-
lence factor or to inject it into the host cell cytoplasm, the
pri-miRNA was not repressed, compared to cells infected
with wild-type H. pylori. These data show that the down-
regulation of the miR-371-372-373 cluster upon H. pylori
infection is mediated by the translocation of CagA into
AGS cells.
To evaluate the effects of the downregulation of miR-372
and miR-373, we analyzed the regulation of their com-
mon target, LATS2, in AGS cells upon H. pylori infec-
tion. We observed that LATS2 mRNA (Figure 4B) and
protein levels (Figure 4C) were inversely correlated to
those of miR-372 and miR-373 upon H. pylori infection.
Indeed, LATS2 protein was drastically upregulated in
infected AGS cells and, likewise, its mRNA level was also
raised up to twofold upon infection. Moreover, similarly
to the pri-miR-371-372-373 repression, LATS2 accumu-
lation was dependent on CagA, as no changes in LATS2
expression were observed either at the mRNA and pro-
tein levels in AGS cells infected with the ΔCagA or
ΔCagE mutants, conversely to wild-type H. pylori
(Figure 4B,C).
T oc o n f i r mt h a tL A T S 2s y n t h e s i sw a sd e r e p r e s s e da t
the post-transcriptional level after miR-372 and miR-373
downregulation in AGS cells infected with wild-type
H. pylori,w eg e n e r a t e das t a b l eL A T S 2r e p o r t e rA G S
cell line expressing a fluorescent sensor containing the
3’UTR of LATS2 downstream of the enhanced green
fluorescent protein (EGFP). This reporter system senses
changes in the miR-372 and miR-373 levels and allows a
direct observation of LATS2 post-transcriptional regula-
tion in living cells. Indeed, as372-373-treated cells, in
which miR-372 and miR-373 levels were decreased, turn
fluorescent, whereas sc372-373 did not [see Additional
File 5, Figure S4]. As depicted in Figure 4D (panel c),
green fluorescence appeared only upon infection with
wild-type H. pylori, mainly in cells exhibiting the hum-
mingbird phenotype (Figure 4D, panels c and d),
whereas uninfected cells (Figure 4D, panels a and b) or
cells infected with the ΔCagA or ΔCagE mutant strains
(Figure 4D, panels e and g) remained non-fluorescent.
We also used this reporter cell line to assess whether
other strains, naturally expressing CagA (type I) or not
(type II), were able to induce LATS2 expression. Indeed,
the P12 type I strain was able to switch on the fluores-
cence of the reporter cells as the 26695 strain did,
whereas type II strains, such as SS1 and X47-2AL, did
not [see Additional File 6, Figure S5B]. We were also
able to correlate this post-transcriptional activation with
a concomitant downregulation of the pri-miR371-372-
373 transcript level [see Additional File 6, Figure S5A].
These data confirm that the CagA-dependent accumula-
tion of LATS2 protein involves a post-transcriptional
release of its expression mediated by the downregulation
of miR-372 and miR-373.
miR-372 and miR-373 downregulation is involved in
H. pylori-induced cell cycle arrest in G1 phase
To assess whether LATS2 upregulation was functionally
relevant, we analyzed cell cycle progression of AGS cells
upon infection. In agreement with previous observations
[31], AGS cells infected for 24 h with wild-type H. pylori
presented a noticeable alteration of the cell cycle, charac-
terized by an accumulation of cells in the G1 phase, in
the detriment of cells in S and G2/M phases [see Addi-
tional File 7, Figure S6]. Accordingly, measuring BrdU
incorporation 24 h post infection, we observed an 80%
reduction of AGS cells in S phase, which reflects a cell
cycle arrest at the G1/S transition (Figure 5A). As already
shown by Murata-Kamiya and colleagues [24], this reduc-
tion was dependent on CagA, as cells infected with the
ΔCagA or ΔCagE mutants did not show such inhibition
of cell cycle progression (Figure 5A [see Additional File
7, Figure S6]). To ascertain that the inhibition of G1/S
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miR-373, we treated AGS cells with synthetic miR-372
and miR-373 prior to infection, in order to dampen their
downregulation upon infection. In this case, the propor-
tion of infected cells in S phase remained as high as in
untreated and uninfected cells (Figure 5B), indicating
that wild-type H. pylori became unable to arrest AGS cell
cycle progression. Conversely, blocking miR-372 and
miR-373 with as372-373 prior to infection facilitated the
infection-induced inhibition of DNA synthesis, which
then reached its maximum (Figure 5B). In addition, silen-
cing LATS2 with siRNA against LATS2 mRNA reduced
the efficiency of H. pylori to block AGS cell cycle (Figure
5C), confirming the LATS2 involvement in the inhibition
of cell cycle progression in infected AGS cells.
The effects of these experimental manipulations of miR-
372 and miR-373 and their common target LATS2 on
the efficiency by which wild-type H. pylori blocks AGS
cell cycle demonstrate that the regulation of these miR-
NAs contribute to the arrest at the G1/S transition in
Figure 4 CagA-dependent repression of primary (pri-)miR-371-372-373 and upregulation of large tumor suppressor homolog 2
(LATS2) expression . (A,B) Expression of the primary miR-371-372-373 cluster transcript (A) or LATS2 mRNA (B) was determined by quantitative
real time PCR (RT-qPCR) in uninfected AGS cells or cells infected for 24 h at multiplicity of infection (MOI) 100 with either Helicobacter pylori
26695 or its ΔCagA or ΔCagE isogenic mutants. Bars indicate the relative pri-micro RNA (miRNA) or LATS2 mRNA expression, normalized to the
ribosomal protein P0 mRNA and compared to uninfected AGS cells. Data are mean ± SD of three independent experiments. **P < 0.01; ***P <
0.001. (C) LATS2 immunoblot of AGS cells infected or not with H. pylori or its isogenic mutants as described above. a-Tubulin was used as a
loading control. (D) Enhanced green fluorescent protein (EGFP) fluorescence of LATS2 reporter cells infected or not with wild-type H. pylori,o r
the ΔCagA or ΔCagE isogenic mutants. Cells were infected as described above and observed 24 h later on an inverted microscope (Zeiss) in
phase contrast (right panels) or epifluorescence (left panels).
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unexpected mechanism involved in the cell cycle arrest
upon infection: the CagA-dependent derepression of
LATS2 by the downregulation of miR-372 and miR-373.
Discussion
Recent data have highlighted the importance of miRNA
in epithelial defense against pathogens such as Cryptos-
poridium parvum [18,19] or Toxoplasma gondii [40].
Gastric mucosa homeostasis is controlled by both
immune and developmental mechanisms and its disrup-
tion by H. pylori infection can lead to severe inflamma-
tory disorders or cancerous lesions of the stomach.
While the impact of pathogens on the miRNA-mediated
regulation of immune responses is beginning to be
precisely understood [41], little is known about bacteria
interfering with miRNAs regulating cell cycle and devel-
opmental pathways. In this study, we report that the bac-
terial pathogen H. pylori specifically downregulates an
embryonic-specific miRNA cluster involved in the
growth regulation of AGS cells, a non-polarized epithelial
cell system commonly used to study H. pylori-host inter-
actions. Through a deep-sequencing approach, we identi-
fied the whole content of miRNAs expressed in this
gastric adenocarcinoma cell line. Among the 38 most
expressed miRNAs, we found several miRNA previously
described in gastric cancer, notably the miR-106b-93-25
cluster, the miR-221-222 cluster, miR-21 and let-7a
[29,42,43]. However, we were surprised to discover that
the most abundant of this repertoire, miR-372, belongs
Figure 5 Role of miR-372 and miR-373 in Helicobacter pylori-induced cell cycle arrest in AGS cells. (A) DNA synthesis rate of uninfected
AGS cells or cells infected for 24 h with wild-type H. pylori or its isogenic mutants ΔCagA and ΔCagE. (B,C) DNA synthesis rate of parental AGS
cells (mock), or treated cells infected with or without wild-type H. pylori for 24 h. Previously, cells were transfected either with 100 nM of a
mixture (1:1) of anti-miR-372 and miR-373 antisense oligonucleotides (as372-373), 25 nM miR-372 and miR-373 double-stranded RNA mimics or
100 nM scrambled oligonucleotides (sc372-373) (B), or treated with 20 nM of anti- large tumor suppressor homolog 2 (LATS2) siRNA or control
siRNA (C). DNA synthesis level was measured by 5-bromo-2’-deoxyuridine (BrdU) pulse labeling. Bars represent the relative BrdU incorporation
level compared to that of uninfected (A) or uninfected parental (B,C) AGS cells. Data are mean ± SD of two independent experiments. *P < 0.05.
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371-5p, miR-371-3p and miR-373, expressed notably in
human embryonic stem cells [34,44]. Interestingly these
miRNAs were also mentioned in a miRNA profiling
study in normal human tissues [35], in which they were
found highly and specifically expressed in placenta, but
also faintly detectable in the testis and stomach.
Functional links of miR-371-372-373 cluster with miR-
106b-93-25 and miR-221-222 in gastric cancer
miR-372 and miR-373 were initially discovered as novel
oncogenes participating in the development of human
testicular germ cell tumors by targeting the cell cycle
inhibitor LATS2 [36]. Interestingly, this embryonic stem
cell miRNA cluster shares some similarities with two
miRNA clusters recently found to be overexpressed in
gastric carcinomas, namely the miR-106b-93-25 cluster
[43] and the miR-221-222 cluster [42]. In gastric cancers,
these two clusters have been described to silence the
CIP/KIP family members, p21
Cip1,p 2 7
Kip1 and p57
Kip2,
allowing the cell to overcome the G1/S checkpoint
[42,43]. Surprisingly, these two clusters are poorly
expressed in AGS cells as compared to other gastric cell
lines and their expression levels are close to those
observed in normal gastric mucosa ([42,43]; Cedric Belair
and Cathy Staedel, unpublished results). One explanation
is that in this cell line, the oncogenic role of these two
clusters could have been replaced by the miR-371-372-
373 cluster overexpression. Indeed, miR-372 and miR-
373 belong to the miR-106b family which includes miR-
93, miR-17-5p and miR-20a [45]. Members of this family
harbor the same seed sequence, stressing that they might
share similar functions. Recently, they have been shown
to overcome the p21
Cip1-induced cell cycle arrest
observed during Ras-induced senescence [45]. In testicu-
lar germ cell tumors, which retained functional, wild-type
p53, miR-372 and miR-373 act as oncogenes, silencing
LATS2 and thus allowing cell proliferation [36]. Indeed,
LATS2 is a serine/threonine kinase involved in a positive
feedback loop with p53 [46] that can induce G1/S arrest
by inhibiting cyclin E/cyclin-dependent kinase 2 (CDK2)
kinase activity [47]. Interestingly, AGS cells express low
wild-type p53 [48] and high p21
cip1/waf1 levels in basal
growth conditions ([49]; Cedric Belair and Cathy Staedel,
unpublished results). Thereby, as in the testicular germ
cell tumors, abundant miR-372 and miR-373 in AGS
cells, that totally silence LATS2, may participate in their
active cell cycle progression despite high levels of p21
cip1/
waf1.
H. pylori represses the miR-371-372-373 expression via its
major virulence factor CagA
We report here that H. pylori specifically inhibits the
synthesis of miR-372 and miR-373 at the primary
transcript level and that this repression relies on CagA
translocation in AGS cells through a functional T4SS.
Very interestingly, these two miRNAs, already described
to promote cell proliferation [36], have also been found to
be repressed upon differentiation of embryonic stem cells
in specific culture conditions [34]. In fact, H. pylori, via its
major virulence factor CagA, can induce an intestinal
transdifferentiation program in gastric epithelial cells that
have undergone a cell cycle arrest [24]. In these cells, the
proliferation is blocked at the G1/S transition after 24 h in
the presence of cagPAI+ H. pylori and this stop is depen-
dent on the translocation of CagA into the host cell
[24,49]. Therefore, one could imagine that the observed
repression of miR-372 and miR-373 in AGS cells could be
a consequence of a block in cell division. However, at 2 h
post infection, when cell proliferation has not been
stopped yet, the pri-miR-371-372-373 was already downre-
gulated close to its minimal level. This latter result sug-
gests that the CagA-dependent repression of this cluster is
a primary event and not a consequence of the cell cycle
arrest. Further investigations may uncover the possible
role of cell signaling pathways in this repression such as
extracellular signal-regulated kinase (ERK), the phosphoi-
nositide 3-kinase (PI3K)/Akt and notably the Src kinase,
the activation of which occurs at this very initial stage of
infection [50].
The cell cycle arrest at the G1/S transition in AGS cells is
mediated by the regulation of the couple miR-372-373/
LATS2 protein
In this paper, we also reveal a new mechanism involved
in the cell cycle arrest in AGS cells upon H. pylori infec-
tion. Indeed, we show that this bacterium induces a
block in cell cycle progression at the G1/S transition via
the post-transcriptional derepression of LATS2 synth-
esis. While several cell cycle regulators have been stu-
died in this context, such as p21
cip1/waf1 [31,49,51], or
p27
kip1 [52,53], our data indicate that an additional
pathway can occur in AGS cells. Indeed, H. pylori is
much less efficient in blocking cell proliferation when
the level of LATS2 is maintained at a low level either by
miR-372 and miR-373 mimics or by specific anti-LATS2
siRNAs. However, because the 3’UTR of p21
cip1/waf1 has
also been proposed to be targeted by miR-372 and miR-
373 [54], we certainly cannot exclude that its induction
also participates in this cell cycle arrest [24,49]. How-
ever, the block at the G1/S transition in AGS cells
requires the derepression of LATS2 synthesis via the
repression of miR-372 and miR-373. Our results with
the EGFP-LATS2 reporter cell line infected with type I
strains, which harbor a functional cagPAI, clearly indi-
cate that H. pylori induce a post-transcriptional release
of LATS2 synthesis in a CagA-dependent manner
through the downregulation of the miRNA cluster.
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Because cagPAI increases the risk for infected patients
to develop severe atrophic gastritis and distal intestinal-
type gastric cancer [55], the perturbations of cell cycle
progression elicited by H. pylori in gastric epithelial cells
gave raise to many studies, some of which having pre-
cisely used AGS cells as a model system of an actively
replicating gastric mucosa [31,51,56]. The miRNA con-
tent in AGS cells is characterized by its relative high
abundance in embryonic stem cell miRNA [see Addi-
tional File 1, Table S2]. In fact, the growth advantages
that AGS cells gained from the high expression of miR-
371-372-373 cluster confer to them characteristics of
gastric stem cell/progenitors rather than gastric mucosa
differentiated epithelium. miR-373 expression has
already been detected in stomach [33]. Epithelium turn-
over, which results from the balanced progenitor cell
generation and differentiated cell death, is a major host
defense mechanism against pathogens and its alteration
is commonly observed upon bacterial infections [57].
Iwai and colleagues have shown that Shigella flexneri
blocks cell cycle of intestinal progenitors through the
injection of its bacterial effector IpaB [58]. In an animal
model, the same group has demonstrated that H. pylori
through CagA delivery suppresses apoptosis at superfi-
cial gastric pit cells, leading to delayed gastric epithe-
lium self-renewal. Hence, it is tempting to speculate that
H. pylori interferes with the gastric epithelium self-
renewal repressing this specific embryonic miRNA clus-
ter in gastric progenitors, an additional mechanism that
Mimuro and coworkers did not observe [57].
Conclusions
The role of miRNAs in severe pathologies, such as cancer,
is now clearly established and extensively studied. Our
work uncovers the unexpected pair of miR-372 and miR-
373 as a novel example of miRNAs dysregulated in gastric
cancer. Repressing LATS2 synthesis, through miR-372 and
miR-373 overexpression, could represent an alternative
pathway to the downregulation of p21
cip1/waf1 or p27
kip1 in
the sequence of events leading to the malignant transfor-
mation of cells. We unveil LATS2/miR-372 and miR-373
as a novel mechanism in CagA-induced cell cycle arrest in
proliferating gastric cells. Our findings enrich the library
of cellular signaling perturbed by the Cag toxin with the
miRNA pathway. Further studies will bring out the bacter-
ial silencing repressor potential of CagA. Finally, our data
are the first findings described so far showing a human
pathogenic bacterium able to interfere with the biogenesis
of a miRNAs cluster through the injection of its CagA
toxin. However it is likely that it will be not the only one,
as injection of toxin through a secretion system in order
to interfere with host cell signaling pathways is a common
virulence mechanism used by human pathogenic Gram-
negative bacteria.
Methods
Cell culture
All the tissue culture reagents were purchased from Invi-
trogen (Paisley, UK ). The AGS gastric epithelial cell line
(ATCC CRL 1739, Manassas, VA, USA) was maintained
in Dulbecco’s modified Eagle medium (DMEM)/F-12
(Ham’s) medium, the other gastric epithelial cell line
MKN-74 (HSRRB FC-2008-028, Osaka, Japan) in RPMI
medium and the cervix cancer cell line (HeLa) in DMEM.
All media were supplemented with 10% heat-inactivated
fetal bovine serum (FBS), 2 mM l-glutamine and 1% non-
essential amino acids. Cells were grown at 37°C in a humi-
dified 5% CO2 atmosphere.
H. pylori culture
H. pylori 26695 strain (CIP 106780, Institut Pasteur, Paris,
France) and its isogenic mutants, as well as P12 (generous
gift of T. Meyer, MPI, Berlin, Germany), SS1 and X47-
2AL (generous gift of H. de Reuse, Institut Pasteur, Paris,
France) strains were grown on columbia agar plates sup-
plemented with 7% laked horse blood, the Dent selective
supplement (Oxoid, Basingstoke, UK), and 20 μg/ml kana-
mycine for the isogenic mutants, for 24 h at 37°C, in anae-
robic jars, under microaerobic conditions (10% CO2,6 %
O2) generated by CampyGen bags (Oxoid, Basingstoke,
UK). After 24 h incubation, the bacteria were expanded
onto fresh plates and grown for an additional 24 h. For
infection, bacteria were harvested in complete Ham’sm e d -
ium and quantified by optical density at 600 nm, assuming
that OD600 = 1 corresponded to 10
9 bacteria.
Construction of H. pylori isogenic mutants
The isogenic knockout mutants 26695 ΔcagA and ΔcagE
were constructed as previously described [59]. The
genomic DNA of H. pylori strain 26695 and the vector
pUC18K2 were used as template for all PCR amplifica-
tions in order to generate the kanamycine resistance
cassette. [see Additional File 1, Table S4 for primers].
Coculture of AGS cells with H. pylori
Before coculture, the culture medium was replaced with
fresh and the bacterial suspension was added to AGS
cells at 60% to 70% confluence at the indicated MOI.
The cocultures were incubated at 37°C, in a humidified
5% CO2 atmosphere.
RNA extraction
Total RNA was extracted using Trizol reagent (Invitro-
gen, Paisley, UK), according to the manufacturer’sp r o -
tocol. RNA concentrations were determined by a
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Inc., Waltham, MA, USA). RNA quality was analyzed on
a 2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA, USA).
454 miRNA libraries
Libraries for ‘454’ pyrosequencing of cDNA were con-
structed by Vertis Biotechnology AG, Freising, Germany
(http://www.vertis-biotech.com/) as described previously
for eukaryotic microRNA in brain [60] and murine macro-
phages [14]. Specifically, total RNA was prepared from
AGS cells either grown in basal conditions or cocultured
for 5 h with H. pylori 26695 strain at MOI 240, and treated
with DNase I. Small RNA species were isolated from
DNase I treated RNA using the mirVana miRNA isolation
kit (Ambion, Austin, Texas, USA). The small RNAs were
separated on a denaturing 12.5% polyacrylamide (PAA) gel
and stained with SYBRgreenII. As molecular mass stan-
dard, a mixture of oligonucleotides was used, also as inter-
nal size marker within the RNA samples. The population
o fm i R N A sw i t hal e n g t ho f1 9t o2 9n u c l e o t i d e sw a s
obtained by passive elution of the RNAs from the gel. The
miRNAs were then precipitated with ethanol and dissolved
in 20 μl water, and 100 ng of RNA was used for cDNA
synthesis. The RNA samples were poly(A)-tailed using
poly(A) polymerase followed by ligation of a RNA adapter
to the 5’-phosphate of the small RNAs. First-strand cDNA
synthesis was then performed using an oligo(dT)-adapter
primer and M-MLV H- reverse transcriptase. Incubation
temperatures were 42°C for 20 min, ramp to 55°C followed
by 55°C for 5 min. The resulting cDNAs were then PCR
amplified using a high fidelity DNA polymerase. The pri-
mers used for PCR amplification were designed for ampli-
con sequencing according to the instructions of 454 Live
Sciences and contain barcode sequences, which are
attached to the 5’-ends of the cDNAs during PCR amplifi-
cation. The following adapter sequences flank the cDNA
inserts: 5’-end (54 bases) (5’-CCATCTCATCCCTGCG
TGTCTCCGACTCAG-NNNNNN-GACCTTGGCTGT-
CACTCA-3) and 3’-end (84 bases) (5’-CCTATCCCCT
GTGTGCCTTGGCAGTCTCAG-ATCAGGCAGAG-
GACGAGACATCGCCCCGC(dT25)-3’). The 454 adapter
sequences are in bold.
The combined length of the flanking sequences was 104
bases. Therefore, PCR products containing miRNA
sequences of 19 to 29 nucleotides must have a total length
of about 120 to 135 bp. PAGE analysis of the PCR-ampli-
fied cDNAs revealed that the cDNAs were of the expected
size. The 120 to 135 bp fractions of the cDNAs were
obtained by separation of the cDNAs on preparative 6%
PAA gels. The eluted cDNAs were finally extracted with
phenol/chloroform and precipitated with ethanol. DNA
pellet was dissolved in 30 μl water. Concentration of the
samples was about 10 ng/μl. The resulting cDNA libraries
were sequenced on a Roche GS20 454 sequencer at the
MPI for Molecular Genetics in Berlin, Germany.
miRNA sequencing analysis
The 454 reads were aligned against the respective set of
mature miRNAs using the R package mirMap454. Briefly,
mirMap454 attempts to identify common 5’ and 3’ adapter
sequences in the reads and removes these prior to further
analysis. Each read is aligned against all mature miRNAs
in the database semiglobally using dynamic programming.
The simple scoring scheme employed allows terminal gaps
in the mature miRNA sequence at no costs, while indels
in general are scored with +3, mismatches with +2 and
mismatches to N with +1. Motivated by the error distribu-
tion of 454 reads, up to three terminal mismatches are
ignored in scoring the alignment if the remainder of the
sequences aligns without indels or mismatches. For each
read, the alignment to a mature miRNA with lowest score
is identified. If the score of this alignment is 5 or less, the
read is considered to be mapped to this miRNA. If the
read maps to n different miRNAs with equal scores, 1/n
reads are counted as mapped to each of these miRNAs
[see Additional File 1, Table S1 for results].
Quantitative RT-PCR
TaqMan microRNA assays (Applied Biosystems, Carlsbad,
CA, USA) were used to quantify the expression of mature
miR-371-3p (AB 002124), miR-372 (AB 000560) and miR-
373 (AB 000561). Real-time RT-qPCR was performed in
triplicate on 20 ng total RNA according to the manufac-
turer’s instructions. miR-372 copy number was deter-
m i n e db ya b s o l u t eR T - q P C R .S a m p l eC tv a l u ew a s
compared to a standard curve determined using serially
diluted synthetic miR-372 [see Additional File 1, Table S4]
and expressed as copies per cell on the basis of our deter-
mination of 1 μg RNA/10
5 AGS cells. LATS2 mRNA and
pri-miR-371-372-373 levels were determined by RT-qPCR
using PerfeCta SYBR Green SuperMix (Quanta BioS-
ciences, Gaithersburg, MD, USA). cDNA was synthesized
with Superscript II reverse transcriptase (Invitrogen, Pais-
ley, UK) using oligo(dT)20 primer according to the manu-
facturer’s protocol [see Additional File 1, Table S4 for
qPCR primers]. miRNAs levels were normalized to U6
small nuclear RNA (snRNA) (RNU6b, AB 001093) or to
SNORD49A (RNU49, AB 001005) in infection experi-
ments, because RNU6b was found affected by the infec-
tion. The levels of LATS2 mRNA or pri-miR-371-372-373
were normalized to the ribosomal protein P0 mRNA. Rela-
tive expressions were calculated using the comparative Ct
method.
Northern blots
Total RNA (20 μg) were resolved on a 15% denaturing
PAA gel and blotted onto nylon membranes (Hybond-N,
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incubated with 5’-
32P-radiolabeled locked nucleic acid
(LNA)/DNA probes in 50% formamide, 5 × SSPE (Saline-
Sodium Phosphate-EDTA), 5 × Denhardt solution, 0.5%
SDS, 20 μg/ml salmon sperm DNA, at 42°C overnight in a
hybridization oven. After two washes for 5 min each in 2
× SSC (Saline-Sodium Citrate), 0.1% SDS at 42°C, the
blots were analyzed and quantified by phosphorimaging
(Molecular Imager PharosFX
plus,B i o R a d ,H e r c u l e s ,C A ,
USA) [see Additional File 1, Table S4 for probe
sequences].
Western blot
Cells were harvested in ice-cold Ham’sm e d i u ma n d
washed with ice cold phosphate-buffered saline (PBS). The
cell pellets were lysed in ProteoJET Mammalian Cell lysis
reagent (Fermentas, St. Leon-Rot, Germany) supplemen-
ted with 5 mM ethylenediaminetetraacetic acid (EDTA)
and 1 × ProteoBlock Protease inhibitor cocktail (Fermen-
tas, St. Leon-Rot, Germany). Proteins were separated by
SDS-PAGE and western blot was performed using Immo-
bilon-P transfer membrane (Millipore), according to stan-
dard procedures. Anti-LATS2 (clone ST-3D10, Abnova,
Taipei City, Taiwan) and anti-a-tubulin (clone B-5-1-2,
Sigma-Aldrich, St. Louis, MO, USA) antibodies were used
at a 1:500 and 1:30,000 dilutions, respectively.
Cell transfections
All transfections were performed using Lipofectamine
2000 (Invitrogen, Paisley, UK) according to the manufac-
turer’s protocol [see Additional File 1, Table S4 for oligo-
nucleotide sequences]. Double-stranded mimic 372-373
were generated by incubating equimolar amounts of com-
plementary, heat-denatured single RNA strands in 60 mM
KCl, 6 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (Hepes) pH 7.5, 0.2 mM MgCl2 buffer, for 20 min at
room temperature. Anti-human LATS2 siRNA (siLATS2)
and control siRNA were purchased from Qiagen (Courta-
boeuf, France). AGS cells were transfected twice with
100 nM of miRNA-antisense (as372-373), 100 nM
scrambled oligonucleotides (sc372-373), or 25 nM double-
s t r a n d e dm i m i c s ,2 0n Ms i L A T S 2o r2 0n Mc o n t r o l
siRNA. pCMVmyc-LATS2 (generous gift of Professor H
Nojima, Osaka, Japan) or the empty vector pcDNA3 (Invi-
trogen, Paisley, UK) were transfected as indicated in the
figure legends. NFB activation was monitored using the
BD Mercury firefly luciferase reporters (BD Biosciences,
Franklin Lakes, NJ, USA) according to the manufacturer’s
instructions. Briefly, 48 h before infection, cells were trans-
fected with either 1 μgN F B-luc or TAL (luciferase with-
out promoter) vectors, together with 10 ng of pRL-SV40
control vector (Promega, Madison, WI, USA). LATS2
translation efficiency was assessed with the luciferase sen-
sors pGL3-LATS2 or its mutant pGL3-LATS2mut [34]
(generous gifts of Professor R Agami, The Netherlands
Cancer Institute, Amsterdam, The Netherlands). Each
plasmid was transfected at 100 ng in the presence of 10 ng
pRL-SV40 control vector (Promega, Madison, WI, USA).
At the second transfection round with as372-373 or
sc372-373, the oligonucleotides were mixed with 100 ng
pGL3-LATS2 or pGL3 plasmids, and 10 ng pRL-SV40
control vector. Firefly and Renilla luciferases were mea-
sured 48 h post transfection using the Dual Luciferase
Assay (Promega, Madison, WI, USA). Firefly luciferase
activities were normalized for transfection efficiency by
Renilla luciferase.
Construction of the LATS2 reporter AGS cell line
The LATS2 3’UTR sequence was obtained by PCR using
pGL3-LATS2 as template [see Additional File 1, Table
S4 for primers]. The PCR product was cloned into the
pEGFP-C1 vector (Clontech, Saint-Germain-en-Laye,
France) downstream to the egfp gene. Stable LATS2
reporter AGS cells were obtained after selection with
400 μg/ml geneticin (Invitrogen, Paisley, UK ) of AGS
cells transfected with the pEGFP-3’UTR-LATS2 vector.
Cell cycle analysis by flow cytometry
After coculture with H. pylori, adherent and floating
cells were collected together, washed once in ice-cold
PBS and fixed in 70% ice-cold ethanol for 24 h. Fixed
cells were stained in a 0.5 mg/ml propidium iodide,
0.1% (w/v) RNAse A, 0.1% (w/v) bovine serum albumin
(BSA)/PBS solution and analyzed for DNA content by
flow cytometry (FACS Canto cytometer, BD Biosciences,
Franklin Lakes, NJ, USA).
BrdU incorporation
AGS cells were transfected twice with as372-373, sc372-
373 or mimic 372-373 before coculture with H. pylori.
Cells were pulse labeled with 10 nM BrdU for 1 h
before the end of the coculture. Cells were harvested
and BrdU incorporation was detected by immunofluor-
escent staining using the fluorescein isothiocyanate
(FITC) BrdU Flow kit (Biosciences, Franklin Lakes, NJ,
USA) and quantified by flow cytometry (FACS Canto
cytometer, BD Biosciences, Franklin Lakes, NJ, USA).
Additional material
Additional file 1: Tables S1-4. Table S1: 454 results of the micro RNA
(miRNA) content in AGS cells in basal conditions and upon Helicobacter
pylori infection (MirBase 14.0). miRNAs studied in this paper are
represented in bold. P values are calculated using Fisher’s exact test.
Table S2: miRNAs listed in regards of their known function. miRNAs
counting more than 100 reads (>0.4% reads) correspond to those in
Figure 1. Table S3: H. pylori strains used in this study. Table S4:
Oligonucleotides used in this study. Sequences are given in the 5’ to 3’
direction. For locked nucleic acid (LNA) oligonucleotides small letters
indicate DNA, whereas capital letters indicate LNA. Antisense miRNA is
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aphA-3’ kanamycin resistance cassette gene are shown in italics, lower
case letters.
Additional file 2: Figure S1. Large tumor suppressor homolog 2 (LATS2)
translation efficiency in AGS (high miR-372 and miR-373) and MKN-74
(low miR-372 and miR-373) cells. AGS or MKN-74 cells were plated at
0.7.10
5 or 10
5 cells/well, respectively, in a 24-well plate and transfected
the following day with 100 ng/well pGL3, pGL3-LATS2 or pGL3-
LATS2mut vectors [36], each mixed with 10 ng pRL-SV40 vector.
Luciferase activities were measured 48 h post transfection. Bars indicate
the relative firefly luciferase activity normalized to the Renilla activity and
compared to pGL3. Data are mean ± SD from three independent
experiments in triplicate. *P < 0.05; ***P < 0.001.
Additional file 3: Figure S2. Effect of antisense oligonucleotides
treatment on micro RNA (miRNA) expression (A,B), large tumor
suppressor homolog 2 (LATS2) expression (D) and cell growth rate (C,E).
(A) Endogenous expression of miR-372, miR-373 and miR-200b was
determined 48 h post transfection by quantitative real time PCR (RT-
qPCR) in untreated cells (mock) or cells treated twice with 100 nM of
locked nucleic acid (LNA)/DNA antisense (as372-373) or scramble (sc372-
373) oligonucleotides [see Additional File 1, Table S4 for sequences]. Bars
indicate relative miRNA expression normalized to U6 small nuclear RNA
(snRNA) (RNU6b). Data are mean ± SD of two independents experiments.
(B) Northern blot analysis of untreated cells (lane 2) or cells treated with
as372 (lane 3), as373 (lane 4), the mix as372-373 (lane 5) or the mix
sc372-373 (lane 6). M: DNA (bp) marker lane (Promega). (C) Comparison
of AGS growth rate between non-treated (mock) or cells treated with
antisense (as372-373, as200b-200c) or scrambled (sc372-373, sc200b-200c)
oligonucleotides. Cells were plated at a density of 10
5 cells per well in a
six-well plate and counted at day 2 and day 3 after plating. The results
are expressed as the relative increase in cell numbers between day 2 and
day 3, normalized to that of untreated AGS cells. Data are mean ± SD of
three independent experiments in duplicate. (D) LATS2 immunoblot of
AGS cells transfected with a pCMVmycLATS2 expression vector, or with
as 372-373 or sc372-373 oligonucleotides. A total of 10
6 AGS cells were
plated in 6 cm diameter plates and transfected the following day with 1
μg pCMVmycLATS2. Oligonucleotide treatments were performed as
above. Proteic lysates were prepared 48 h post transfection and
submitted to SDS-PAGE. a-Tubulin was used as a loading control. A
representative immunoblot is shown. (E) Effect of ectopic expression of
LATS2 on AGS or MKN74 growth rate. Black bars, cells transfected with
pCMVmycLATS2; grey bars, cells transfected with pcDNA3. Cells were
plated at a density of 10
3 cells/well in a 96-well plate containing 22 ng/
well plasmid. Cell viability was determined at day 2 and day 3 after
plating by optical density later using the Celltiter Proliferation Assay
(Promega). The results are expressed as the relative increase in optical
density between day 2 and day 3, normalized to that of pcDNA3-
transfected cells. Data are mean ± SD of two independent experiments
performed in triplicate.
Additional file 4: Figure S3. Helicobacter pylori-induced morphological
changes (A) and proinflammatory responses (B,C) in AGS cells. (A)
Morphology of uninfected AGS cells or cells infected for 24 h with H.
pylori 26695 wild-type strain or its isogenic mutants H. pylori ΔCagA and
ΔCagE at multiplicity of infection (MOI) 100 was visualized by phase
contrast microscopy. Uninfected AGS cells display an epithelial
morphology. Coculture with H. pylori 26695 wild-type strain causes cell
elongation, so called ‘hummingbird’ phenotype, and vacuoles. The
‘hummingbird’ phenotype is CagA dependent, as cells cocultured with H.
pylori 26695 mutated for the CagA toxin (H. pylori ΔCagA) or unable to
inject CagA (H. pylori ΔCagE) harbor only vacuoles, an effect due to the
VacA toxin secreted into the culture medium. (B,C) Proinflammatory
responses of AGS cells infected for 24 h with H. pylori 26695 wild-type
strain or its isogenic mutants ΔCagA and ΔCagE at MOI 100 were
analyzed by nuclear factor (NF)B activation (B) and interleukin 8 (IL-8)
secretion (C). As previously described [26], NFB activation and IL-8
secretion were both CagA and Type IV Secretion System dependent.
NFB activation was monitored using the BD Mercury firefly luciferase
reporters (Beckton-Dickinson) containing NFB binding sites upstream of
the firefly luciferase. Bars indicate the firefly luciferase activity normalized
to Renilla luciferase, minus TAL (luciferase without promoter) activity.
Data represent the mean ± SD of two independent experiments. IL-8
secreted in the culture medium was measured 24 h post infection using
ELISA (R&D systems). The results represent the mean ± SD of four
independent experiments.
Additional file 5: Figure S4. Enhanced green fluorescent protein (EGFP)
fluorescence of large tumor suppressor homolog 2 (LATS2) reporter-AGS
cells transfected with as372-373 or sc372-373. Cells were transfected
twice with 100 nM antisense or scramble oligonucleotides and observed
24 h after the last transfection on an inverted microscope (Zeiss) in
phase contrast (right panels) or epifluorescence (left panels).
Additional file 6: Figure S5. Helicobacter pylori strain-specific repression
of primary (pri-)miR-371-372-373 and upregulation of the enhanced
green fluorescent protein (EGFP)-3’ untranslated region (UTR) large tumor
suppressor homolog 2 (LATS2) reporter gene. AGS cells were infected
with H. pylori type I strains (P12) or type II strain (SS1, X47) at a
multiplicity of infection (MOI) 100 for 24 h. (A) Expression of the pri-miR-
371-372-373 was determined by quantitative real time PCR (RT-qPCR) in
non-infected cells (NI) or cells infected with the different H. pylori strains.
Bars indicate relative pri-micro RNA (miRNA) expression normalized to
ribosomal protein P0. A representative experiment is shown. (B) EGFP
fluorescence of LATS2 reporter cells infected or not with H. pylori strains.
Cells were observed 24 h post infection on an inverted microscope
(Zeiss) in phase contrast (right panels) or epifluorescence (left panels).
Additional file 7: Figure S6. CagA-dependent accumulation of
Helicobacter pylori-infected AGS cells in G0/G1 phase. Cellular DNA
contents of uninfected AGS cells or cells infected for 24 h with wild-type,
ΔCagA or ΔCagE H. pylori were stained by iodide propidium and
analyzed by flow cytometry.
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